(Q43548682)

English

Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy (English)

1 reference

Europe PubMed Central

24 November 2017

author name string

Wilson CS

1

1 reference

Europe PubMed Central

24 November 2017

Butch AW

2

1 reference

Europe PubMed Central

24 November 2017

Lai R

3

1 reference

Europe PubMed Central

24 November 2017

Medeiros LJ

4

1 reference

Europe PubMed Central

24 November 2017

Sawyer JR

5

1 reference

Europe PubMed Central

24 November 2017

Barlogie B

6

1 reference

Europe PubMed Central

24 November 2017

McCourty A

7

1 reference

Europe PubMed Central

24 November 2017

Kelly K

8

1 reference

Europe PubMed Central

24 November 2017

Brynes RK

9

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

24 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

24 November 2017

112

1 reference

Europe PubMed Central

24 November 2017

776-782

1 reference

Europe PubMed Central

24 November 2017

3

1 reference

Europe PubMed Central

24 November 2017

Cytoplasmic immunoglobulin content in multiple myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

The E2F transcription factor is a cellular target for the RB protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Expression of transcription factor E2F1 induces quiescent cells to enter S phase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Cyclins and oncogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Cancer cell cycles

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02499.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02499.X

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43548682&oldid=2098242617"